Sponsor Pipeline

Faron Pharmaceuticals Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07672769 Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With… Higher Risk Myelodysplastic Syndromes Not Yet Recruiting
Phase 1/2
NCT05428969 A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in… Acute Myeloid Leukemia Active, Not Recruiting
Disease Areas
Myelodysplastic Syndromes (MDS) (2) Leukemia (1) Acute Myeloid Leukemia (AML) (1)
Get alerts when Faron Pharmaceuticals Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free